EUVIMEDEUVIMED entdecken
Open Access

All-cause mortality, adverse events and associated factors following endoscopic retrograde cholangiopancreatography for benign indications in England

Gesamtmortalität, unerwünschte Ereignisse und assoziierte Faktoren nach ERCP bei benignen Indikationen in England

Umair Kamran iD, Philip R Harvey, Ben Coupland, Jemma Mytton, Kofi W Oppong iD, Nigel Trudgill

Endoscopy International Open · 08.06.2026 · 14 (CP)

DOI: 10.1055/a-2865-3052 ↗

Auf einen Blick

Bei 283.972 Erwachsenen mit ERCP wegen benignen Indikationen sank die 30-Tage-Gesamtmortalität im Studienzeitraum um 31 %. Alter, männliches Geschlecht, Komorbidität und weitere Faktoren waren mit der Mortalität assoziiert.

Fragestellung

Welche Mortalität, unerwünschten Ereignisse und Faktoren sind bei Erwachsenen nach erster ERCP wegen benignen Indikationen in England mit dem Ausgang assoziiert?

Methode

Populationsbasierte Auswertung von Hospital-Episode-Statistics-Daten zu Erwachsenen mit erster ERCP wegen benignen Indikationen 2003–2020 in England; 30-Tage-Mortalität und 7-Tage-UAW; multivariable logistische Regression.

Ergebnisse

283.972 Patient:innen; 63,4 % weiblich; medianes Alter 67 Jahre (IQR 50–79). 25 % der ERCPs 2019/2020 bei Charlson-Score ≥ 5 vs. 8 % 2003/2004. 3 % der Day-Case-ERCPs mit notfallmäßiger Wiederaufnahme wegen Pankreatitis. 30-Tage-Mortalität um 31 % gefallen.

Schlussfolgerung der Autor:innen

Trotz älterer und multimorbider Patient:innen mit ERCP wegen benignen Indikationen sank die 30-Tage-Gesamtmortalität um 31 %. Die Mortalität war mit Alter, männlichem Geschlecht, Komorbidität, schwarzer Ethnie, Notfall-ERCP und Volumen assoziiert.

Kernaussagen

  • 30-Tage-Gesamtmortalität sank im Studienzeitraum um 31 %
  • Mortalität war u. a. mit Alter, männlichem Geschlecht und Komorbidität assoziiert
  • Es zeigten sich Unterschiede zwischen ERCP-Anbietern

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 08.06.2026. Verfasst von Umair Kamran und 5 weiteren Autor:innen. Beteiligte Einrichtung: HPB Unit and Department of GastroenterologyNewcastle Upon Tyne Hospitals NHS Foundation TrustNewcastle Upon TyneUnited Kingdom of Great Britain and N…. Der Volltext ist frei in PubMed Central verfügbar.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and study aims Population-based data on outcomes of endoscopic retrograde cholangiopancreatography (ERCP) for benign indications are limited. We examined the impact of changing patient demographics on ERCP outcomes. Patients and methods Adults undergoing first ERCP for benign indications between 2003 and 2020 in England were identified in Hospital Episode Statistics. All-cause mortality within 30 days and adverse event rates within 7 days were calculated. Multivariable logistic regression analysis explored factors associated with all-cause mortality.

Results

A total of 283,972 patients were included; 63.4% female; median age 67 years (interquartile range 50–79). Twenty-five percent of ERCPs in 2019/2020 were performed in patients with a Charlson comorbidity score ≥ 5, compared with 8% in 2003/2004. Three percent of patients who underwent day case ERCP had an emergency readmission with pancreatitis. Thirty-day all-cause mortality fell by 31% over the study period. Mortality was associated with age (age quintile ≥ 82 years; odds ratio 19.22; 95% confidence interval [CI] 15.59–23.69 compared with 18–46 years), male sex (1.21; CI 1.14–1.27), Black or Black British ethnicity (1.42; CI 1.07–1.90), increasing comorbidity score ≥ 5 (3.35; CI 3.14–3.57), and increasing provider annual ERCP volume (volume ≥ 151; 1.08; CI 1.01–1.16). Elective ERCP (0.30; CI 0.28–0.33) and those in recent years were associated with lower mortality (2019/2020 compared with 2003/2004 (0.40; CI 0.34–0.48). Statistically significant variations in 30-day all-cause mortality were observed between ERCP providers.

Conclusions

Despite the increasing age and comorbidities of patients undergoing ERCP for benign indications, 30-day all-cause mortality fell by 31% in recent years. All-cause mortality was associated with age, males, comorbidities, black ethnicity, emergency ERCP, and increasing provider volume.

Schlagwörter

Stichwörter der Autor:innen

ERC topicsPancreatobiliary (ERCP/PTBD)StonesStrictures

Autor:innen und Institutionen

  • HPB Unit and Department of GastroenterologyNewcastle Upon Tyne Hospitals NHS Foundation TrustNewcastle Upon TyneUnited Kingdom of Great Britain and Northern Ireland.
  • Department of GastroenterologyRoyal Wolverhampton Hospitals NHS TrustWolverhamptonUnited Kingdom of Great Britain and Northern Ireland.
  • Department of Health InformaticsUniversity Hospitals Birmingham NHS Foundation TrustBirminghamEnglandUnited Kingdom of Great Britain and Northern Ireland.
  • Institute of Translational and Clinical ResearchNewcastle UniversityNewcastle upon TyneEnglandUnited Kingdom of Great Britain and Northern Ireland.
  • Department of GastroenterologySandwell and West Birmingham NHS TrustWest BromwichUnited Kingdom of Great Britain and Northern Ireland.
  • Department of Cancer and Genomic SciencesUniversity of BirminghamBirminghamEnglandUnited Kingdom of Great Britain and Northern Ireland.

ORCID-Profile: Umair Kamran, Kofi W Oppong

Zitieren

APA

Kamran, U., Harvey, P. R., Coupland, B., Mytton, J., Oppong, K. W., & Trudgill, N. (2026). All-cause mortality, adverse events and associated factors following endoscopic retrograde cholangiopancreatography for benign indications in England. Endoscopy International Open, 14(CP). https://doi.org/10.1055/a-2865-3052

Vancouver

Kamran U, Harvey PR, Coupland B, Mytton J, Oppong KW, Trudgill N. All-cause mortality, adverse events and associated factors following endoscopic retrograde cholangiopancreatography for benign indications in England. Endoscopy International Open. 2026;14(CP). doi:10.1055/a-2865-3052

BibTeX
@article{Kamran2026,
  author = {Kamran, Umair and Harvey, Philip R and Coupland, Ben and Mytton, Jemma and Oppong, Kofi W and Trudgill, Nigel},
  title = {All-cause mortality, adverse events and associated factors following endoscopic retrograde cholangiopancreatography for benign indications in England},
  journal = {Endoscopy International Open},
  year = {2026},
  volume = {14},
  number = {CP},
  doi = {10.1055/a-2865-3052}
}
Kostenlos starten →